Skip to Content
Global News Select

Merck KGaA to Invest Around $465 Million to Expand Operations in Ireland

By Cecilia Butini

 

Merck KGaA said Monday that it would invest about 440 million euros ($464.8 million) to expand manufacturing in membrane and filtration, as part of its life-science business, in Ireland.

The German pharmaceuticals and chemicals company said the investment is to increase membrane-manufacturing capacity in Carrigtwohill and to build a new site for filtration manufacture at Blarney Business Park. Both facilities are going to be in Cork.

"Ireland is central to our strategy to drive long-term growth and expand our global leadership position in Life Science," said Matthias Heinzel, chief executive of Merck's Life Science business, which is one of the company's growth drivers.

Membrane production is also set to benefit the company's Process Solutions business, another key growth driver for Merck, the company said.

 

Write to Cecilia Butini at cecilia.butini@wsj.com

 

(END) Dow Jones Newswires

May 23, 2022 05:38 ET (09:38 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.